A sphingolipid mechanism for behavioral extinction

Journal of Neurochemistry

Volumn 137, Issue 4, 2016, Pages 589-603

  Huston, Joseph P ^a   Kornhuber, Johannes ^b   Mühle, Christiane ^b   Japtok, Lukasz ^c   Komorowski, Mara ^a   Mattern, Claudia ^d,e   Reichel, Martin ^b   Gulbins, Erich ^f,g   Kleuser, Burkhard ^c   Topic, Bianca ^a   De Souza Silva, Maria A ^a   Müller, Christian P ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF POTSDAM   (Germany)

^d M et P Pharma AG   (Switzerland)

^e NOVA SOUTHEASTERN UNIVERSITY   (United States)

^f UNIVERSITY OF DUISBURG ESSEN   (Germany)

^g UNIVERSITY OF CINCINNATI   (United States)

Author keywords

acid sphingomyelinase; ceramide; extinction; hippocampus; operant behavior; sphingomyelin

Indexed keywords

CERAMIDE; DOPAMINE; NEUTRAL CERAMIDASE; SPHINGOLIPID; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE;

ADULT; AGED; AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CEREBELLUM; CONDITIONING; CONTROLLED STUDY; CORRELATIONAL STUDY; DEPRESSION; DORSAL HIPPOCAMPUS; ENZYME ACTIVITY; LIPID BRAIN LEVEL; LIPIDOMICS; MALE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; RAT; REWARD; VENTRAL HIPPOCAMPUS; ANIMAL; INSTRUMENTAL CONDITIONING; METABOLISM; PHYSIOLOGY; REACTION TIME; REINFORCEMENT; WISTAR RAT;

ANIMALS; CERAMIDES; CONDITIONING, OPERANT; EXTINCTION, PSYCHOLOGICAL; MALE; RATS; RATS, WISTAR; REACTION TIME; SPHINGOLIPIDS; SPHINGOMYELINS;

EID: 84960968218     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13537     Document Type: Article

References (72)

1. Babenko N. A., and, Semenova Y. A., (2010) Effects of long-term fish oil-enriched diet on the sphingolipid metabolism in brain of old rats. Exp. Gerontol. 45, 375-380.
2. Bast T., (2007) Toward an integrative perspective on hippocampal function: from the rapid encoding of experience to adaptive behavior. Rev. Neurosci. 18, 253-281.
3. Bentosela M., Ruetti E., Muzio R. N., Mustaca A. E., and, Papini M. R., (2006) Administration of corticosterone after the first downshift trial enhances consummatory successive negative contrast. Behav. Neurosci. 120, 371-376.
4. Biesdorf C., Wang A.-L., Topic B., Petri D., Milani H., Huston J. P., and, de Souza Silva M. A., (2015) Dopamine in the nucleus accumbens core, but not shell, increases during signaled food reward and decreases during delayed extinction. Neurobiol. Learn. Mem. 123, 125-139.
5. Brown D. A., and, London E., (1998) Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 14, 111-136.
6. Buddenberg T. E., Topic B., Mahlberg E. D., De Souza Silva M. A., Huston J. P., and, Mattern C., (2008) Behavioral actions of intranasal application of dopamine: effects on forced swimming, elevated plus-maze and open field parameters. Neuropsychobiology 57, 70-79.
7. Carpinteiro A., Becker K. A., Japtok L., Hessler G., Keitsch S., Požgajovà M., et al,. (2015) Regulation of hematogenous tumor metastasis by acid sphingomyelinase. EMBO Mol. Med. 7, 714-734.
8. Carrasco P., Sahun I., McDonald J., Ramirez S., Jacas J., Gratacos E., et al,. (2012) Ceramide levels regulated by carnitine palmitoyltransferase 1C control dendritic spine maturation and cognition. J. Biol. Chem. 287, 21224-21232.
9. Chaudhury D., Walsh J. J., Friedman A. K., Juarez B., Ku S. M., Koo J. W., et al,. (2013) Rapid regulation of depression-related behaviors by control of midbrain dopamine neurons. Nature 493, 532-536.
10. Cremesti A. E., Goni F. M., and, Kolesnick R., (2002) Role of sphingomyelinase and ceramide in modulating rafts: do biophysical properties determine biologic outcome? FEBS Lett. 531, 47-53.
11. De Souza Silva M. A., Topic B., Huston J. P., and, Mattern C., (2008) Intranasal dopamine application increases dopaminergic activity in the neostriatum and nucleus accumbens and enhances motor activity in the open field. Synapse 62, 176-184.
12. Delint-Ramirez I., Salcedo-Tello P., and, Bermudez-Rattoni F., (2008) Spatial memory formation induces recruitment of NMDA receptor and PSD-95 to synaptic lipid rafts. J. Neurochem. 106, 1658-1668.
13. Ebel P., Vom D. K., Petrasch-Parwez E., et al,. (2013) Inactivation of ceramide synthase 6 in mice results in an altered sphingolipid metabolism and behavioral abnormalities. J. Biol. Chem. 288, 21433-21447.
14. Fantini J., and, Barrantes F. J., (2009) Sphingolipid/cholesterol regulation of neurotransmitter receptor conformation and function. Biochim. Biophys. Acta 1788, 2345-2361.
15. Ginkel C., Hartmann D., vom Dorp K., et al,. (2012) Ablation of neuronal ceramide synthase 1 in mice decreases ganglioside levels and expression of myelin-associated glycoprotein in oligodendrocytes. J. Biol. Chem. 287, 41888-41902.
16. Gourley S. L., and, Taylor J. R., (2009) Recapitulation and reversal of a persistent depression-like syndrome in rodents. Curr. Protoc. Neurosci. Chapter 9: Unit. 9.32. doi: 10.1002/0471142301.ns0932s49
17. Gregus A., Wintink A. J., Davis A. C., and, Kalynchuk L. E., (2005) Effect of repeated corticosterone injections and restraint stress on anxiety and depression-like behavior in male rats. Behav. Brain Res. 156, 105-114.
18. Gulbins E., Palmada M., Reichel M., Lüth A., Böhmer C., Amato D., Müller C. P., et al,. (2013) Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs. Nat. Med. 19, 934-938.
19. Hammen C., (2005) Stress and depression. Annu. Rev. Clin. Psychol. 1, 293-319.
20. Hannun Y. A., and, Obeid L. M., (2008) Principles of bioactive lipid signaling: lessons from sphingolipids. Nat. Rev. Mol. Cell Biol. 9, 139-150.
21. Henry B. D., Neill D. R., Becker K. A., Gore S., Bricio-Moreno L., Ziobro R., et al,. (2015) Engineered liposomes sequester bacterial exotoxins and protect from severe invasive infections in mice. Nat. Biotechnol. 33, 81-88.
22. Huston J. P., van den Brink J., Komorowski M., Huq Y., and, Topic B., (2012) Antidepressants reduce extinction-induced withdrawal and biting behaviors: a model for depressive-like behavior. Neuroscience 210, 249-257.
23. Huston J. P., Silva M. A., Komorowski M., Schulz D., and, Topic B., (2013) Animal models of extinction-induced depression: loss of reward and its consequences. Neurosci. Biobehav. Rev. 37, 2059-2070.
24. Izquierdo A., Wellman C. L., and, Holmes A., (2006) Brief uncontrollable stress causes dendritic retraction in infralimbic cortex and resistance to fear extinction in mice. J. Neurosci. 26, 5733-5738.
25. Jain M., Ngoy S., Sheth S. A., Swanson R. A., Rhee E. P., Liao R., Clish C. B., Mootha V. K., and, Nilsson R., (2014) A systematic survey of lipids across mouse tissues. Am. J. Physiol. Endocrinol. Metab. 306, E854-E868.
26. Kessler R. C., (1997) The effects of stressful life events on depression. Annu. Rev. Psychol. 48, 191-214.
27. Kolesnick R. N., Goni F. M., and, Alonso A., (2000) Compartmentalization of ceramide signaling: physical foundations and biological effects. J. Cell. Physiol. 184, 285-300.
28. Komorowski M., Huston J. P., Klingenhegel I., Paulat J., Sackers J., and, Topic B., (2012) Distance from source of reward as a marker for extinction-induced "despair": modulation by the antidepressants clomipramine and citalopram. Neuroscience 223, 152-162.
29. Kornhuber J., Medlin A., Bleich S., Jendrossek V., Henkel A. W., Wiltfang J., and, Gulbins E., (2005) High activity of acid sphingomyelinase in major depression. J. Neural. Transm. 112, 1583-1590.
30. Kornhuber J., Müller C. P., Becker K. A., Reichel M., and, Gulbins E., (2014) The ceramide system as a novel antidepressant target. Trends Pharmacol. Sci. 35, 293-304.
31. Kornhuber J., Rhein C., Müller C. P., and, Mühle C., (2015) Secretory sphingomyelinase in health and disease. Biol. Chem. 396, 707-736.
32. Lahiri S., and, Futerman A. H., (2007) The metabolism and function of sphingolipids and glycosphingolipids. Cell. Mol. Life Sci. 64, 2270-2284.
33. Lekman A., Skjeldal O., Sponheim E., and, Svennerholm L., (1995) Gangliosides in children with autism. Acta Paediatr. 84, 787-790.
34. Liebisch G., Drobnik W., Reil M., Trümbach B., Arnecke R., Olgemöller B., Roscher A., and, Schmitz G., (1999) Quantitative measurement of different ceramide species from crude cellular extracts by electrospray ionization tandem mass spectrometry (ESI-MS/MS). J. Lipid Res. 40, 1539-1546.
35. Lucki I., and, Frazer A., (1985) Performance and extinction of lever press behavior following chronic administration of desipramine to rats. Psychopharmacology 85, 253-259.
36. McEwen B. S., (1999) Stress and hippocampal plasticity. Ann. Rev. Neurosci.; 22: 105-122.
37. van Meer G., Voelker D. R., and, Feigenson G. W., (2008) Membrane lipids: where they are and how they behave. Nat. Rev. Mol. Cell Biol. 9, 112-124.
38. Miracle A. D., Brace M. F., Huyck K. D., Singler S. A., and, Wellman C. L., (2006) Chronic stress impairs recall of extinction of conditioned fear. Neurobiol. Learn. Mem. 85, 213-218.
39. Müller C. P., Reichel M., Mühle C., Rhein C., Gulbins E., and, Kornhuber J., (2015) Brain membrane lipids in major depression and anxiety disorders. Biochim. Biophys. Acta 1851, 1052-1065.
40. Nesse R. M., and, Berridge K. C., (1997) Psychoactive drug use in evolutionary perspective. Science 278, 63-66.
41. Nevin J. A., (2012) Resistance to extinction and behavioral momentum. Behav. Processes 90, 89-97.
42. Nevin J. A., and, Grace R. C., (2000) Behavioral momentum and the law of effect. Behav. Brain Sci. 23, 73-90.
43. Norman E., Cutler R. G., Flannery R., Wang Y., and, Mattson M. P., (2010) Plasma membrane sphingomyelin hydrolysis increases hippocampal neuron excitability by sphingosine-1-phosphate mediated mechanisms. J. Neurochem. 114, 430-439.
44. Nothdurfter C., Tanasic S., Di B. B., Rammes G., Wagner E. M., Kirmeier T., et al,. (2010) Impact of lipid raft integrity on 5-HT3 receptor function and its modulation by antidepressants. Neuropsychopharmacology 35, 1510-1519.
45. Nothdurfter C., Tanasic S., Di B. B., Uhr M., Wagner E. M., Gilling K. E., et al,. (2013) Lipid raft integrity affects GABAA receptor, but not NMDA receptor modulation by psychopharmacological compounds. Int. J. Neuropsychopharmacol. 16, 1361-1371.
46. Oliveira T. G., Chan R. B., Bravo F. V., Miranda A., Silva R. R., and, Zhou B., et al,. (2016). The impact of chronic stress on the rat brain lipidome. Mol. Psychiatry 21, 80-88.
47. Papini M. R., (2003) Comparative psychology of surprising nonreward. Brain Behav. Evol. 62, 83-95.
48. Papini M. R., and, Dudley R. T., (1997) Consequences of surprising reward omissions. Rev. Gen. Psychol. 1, 175-197.
49. Pinkston J. W., Ginsburg B. C., and, Lamb R. J., (2014) Reinforcer magnitude and rate dependency: evaluation of resistance-to-change mechanisms. Behav. Pharmacol. 25, 629-636.
50. Quick S. L., and, Shahan T. A., (2015) The impact of D-amphetamine and SCH23390 on behavioral momentum of food seeking and reinstatement in rats. Behav. Pharmacol. 26, 249-259.
51. Quirk G. J., and, Mueller D., (2008) Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 33, 56-72.
52. Rawlins J. N., Feldon J., and, Gray J. A., (1980) The effects of hippocampectomy and of fimbria section upon the partial reinforcement extinction effect in rats. Exp. Brain Res. 38, 273-283.
53. Rossato J. I., Bevilaqua L. R., Lima R. H., Medina J. H., Izquierdo I., and, Cammarota M., (2006) On the participation of hippocampal p38 mitogen-activated protein kinase in extinction and reacquisition of inhibitory avoidance memory. Neuroscience 143, 15-23.
54. Ruetti E., Justel N., Mustaca A. E., and, Papini M. R., (2009) Posttrial corticosterone administration enhances the effects of incentive downshift: exploring the boundaries of this effect. Behav. Neurosci. 123, 137-144.
55. Ruocco L. A., de Souza Silva M. A., Topic B., Mattern C., Huston J. P., and, Sadile A. G., (2009) Intranasal application of dopamine reduces activity and improves attention in Naples High Excitability rats that feature the mesocortical variant of ADHD. Eur. Neuropsychopharmacol. 19, 693-701.
56. Sacket S. J., Chung H. Y., Okajima F., and, Im D. S., (2009) Increase in sphingolipid catabolic enzyme activity during aging. Acta Pharmacol. Sin. 30, 1454-1461.
57. Schengrund C. L., Ali-Rahmani F., and, Ramer J. C., (2012) Cholesterol, GM1, and autism. Neurochem. Res. 37, 1201-1207.
58. Schnaar R. L., Gerardy-Schahn R., and, Hildebrandt H., (2014) Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration. Physiol. Rev. 94, 461-518.
59. Schwabe L., and, Wolf O. T., (2011) Stress increases behavioral resistance to extinction. Psychoneuroendocrinology 36, 1287-1293.
60. Scully J. A., Tosi H., and, Banning K., (2000) Live event checklist: revisiting the social readjustment rating scale after 30 years. Educ. Psychol. Measurement 60, 864-876.
61. Sebastiao A. M., Colino-Oliveira M., Assaife-Lopes N., Dias R. B., and, Ribeiro J. A., (2013) Lipid rafts, synaptic transmission and plasticity: impact in age-related neurodegenerative diseases. Neuropharmacology 64, 97-107.
62. Shull R. L., Gaynor S. T., and, Grimes J. A., (2002) Response rate viewed as engagement bouts: resistance to extinction. J. Exp. Anal. Behav. 77, 211-231.
63. Simons K., and, Toomre D., (2000) Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1, 31-39.
64. Stenkamp K., Heinemann U., and, Schmitz D., (1998) Dopamine suppresses stimulus-induced field potentials in layer III of rat medial entorhinal cortex. Neurosci. Lett. 255, 119-121.
65. Szapiro G., Vianna M. R., McGaugh J. L., Medina J. H., and, Izquierdo I., (2003) The role of NMDA glutamate receptors, PKA, MAPK, and CAMKII in the hippocampus in extinction of conditioned fear. Hippocampus 13, 53-58.
66. Tabatadze N., Savonenko A., Song H., Bandaru V. V., Chu M., and, Haughey N. J., (2010) Inhibition of neutral sphingomyelinase-2 perturbs brain sphingolipid balance and spatial memory in mice. J. Neurosci. Res. 88, 2940-2951.
67. Todd T. P., Vurbic D., and, Bouton M. E., (2014) Behavioral and neurobiological mechanisms of extinction in Pavlovian and instrumental learning. Neurobiol. Learn. Mem. 108, 52-64.
68. Trossbach S. V., de Souza Silva M. A., Huston J. P., Korth C., and, Mattern C., (2014) Intranasal dopamine treatment reinstates object-place memory in aged rats. Neurobiol. Learn. Mem. 114, 231-235.
69. Vyas T. K., Shahiwala A., Marathe S., and, Misra A., (2005) Intranasal drug delivery for brain targeting. Curr. Drug Deliv. 2, 165-175.
70. Willner P., (1997) The mesolimbic dopamine system as a target for rapid antidepressant action. Int. Clin. Psychopharmacol. 12 (Suppl 3), S7-S14.
71. Willner P., Hale A. S., and, Argyropoulos S., (2005) Dopaminergic mechanism of antidepressant action in depressed patients. J. Affect. Disord. 86, 37-45.
72. Yang S. N., (2000) Ceramide-induced sustained depression of synaptic currents mediated by ionotropic glutamate receptors in the hippocampus: an essential role of postsynaptic protein phosphatases. Neuroscience 96, 253-258.